论文部分内容阅读
目的:观察探讨依达拉奉与丹参注射液联合方案治疗急性脑梗塞的临床效果。方法:收集2014年1月-2016年8月期间我院收治的急性脑梗塞患者40例,按照单盲的原则将这40例患者均分为对照组和观察组,对照组的20例患者接受丹参注射液治疗,观察组的20例患者接受依达拉奉与丹参注射液联合治疗,观察比较两组患者的临床治疗效果。结果:观察组临床治疗总有效率90%优于对照组70%;观察组患者治疗后的全血黏度、血浆黏度以及纤维蛋白原均明显优于对照组,(P<0.05)具有统计学意义。结论:依达拉奉与丹参注射液联合方案治疗急性脑梗塞的临床效果显著,能够有效的改善患者血液流变学状态,值得推广。
Objective: To observe the clinical effect of edaravone and salvia miltiorrhiza injection on acute cerebral infarction. Methods: Forty patients with acute cerebral infarction admitted from January 2014 to August 2016 in our hospital were enrolled. According to the principle of single-blind, all 40 patients were divided into control group and observation group. 20 patients in control group received Salvia injection treatment, the observation group of 20 patients received edaravone and Salvia injection joint treatment, the clinical efficacy of the two groups were observed and compared. Results: The total effective rate of clinical observation in observation group was 90% better than that in control group (70%). The whole blood viscosity, plasma viscosity and fibrinogen in observation group were significantly better than those in control group (P <0.05) . Conclusion: The combination of edaravone and salvia miltiorrhiza injection in the treatment of acute cerebral infarction has significant clinical effect, which can effectively improve the hemorheological status of patients and is worth popularizing.